In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo
Annals of Internal Medicine · 2024
DOI: 10.7326/j24-0024 ↗Kurz gefasst
Kommentar in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Andrew Dunn. Beteiligte Einrichtung: Icahn Mount Sinai School of Medicine, New York, NY, USA (A.D.). Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Hemorrhage, Vitamin K. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Icahn Mount Sinai School of Medicine, New York, NY, USA (A.D.).
Zitieren
APA
Dunn, A. (2024). In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo. Annals of Internal Medicine. https://doi.org/10.7326/j24-0024
Vancouver
Dunn A. In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo. Annals of Internal Medicine. 2024. doi:10.7326/j24-0024
BibTeX
@article{Dunn2024,
author = {Dunn, Andrew},
title = {In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo},
journal = {Annals of Internal Medicine},
year = {2024},
doi = {10.7326/j24-0024}
}
EUVIMED